CMB.TECH NV (CMBT)
Euronext Brussels · Belgium · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 16.58 |
|---|---|
| 52-week range | 7.77 – 19.10 |
| Return, 1 month / 3 months | +1.8% / +24.8% |
| Return, 1 year / 3 years | +120.6% / +53.4% |
| Trend | Uptrend |
| RSI (14) | 52 |
| Volatility (1 year) | 40.8% |
| Worst drawdown (1 year) | -16.0% |
| Average daily value traded | 2.34M EUR |
| Dividend yield | 7.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
CMB.TECH NV is a Belgian shipping company based in Antwerp that operates a fleet of crude oil tankers serving the international energy trade. Alongside its conventional tanker activities, the company develops and runs vessels powered by alternative fuels such as hydrogen and ammonia, and it produces and distributes these fuels through its own operations. Its customers are mainly oil companies, traders and industrial shippers who need large-scale marine transport and lower-emission fuel solutions.
The shares are listed on the Euronext Brussels in Belgium under the code CMBT, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
CMB.TECH NV (CMBT) trades on the Euronext Brussels in Belgium. It last closed at EUR 16.58 on 23 October 2026.
Its price-based Market X-Ray is 81 out of 100 (a strong price profile), ranking 5 of 111 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 120.6% and over the last three months it rose 24.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Brussels
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 88 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 31.3% | ||
| From 52-week high | -11.5% | ||
| Momentum | 99 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 24.8% | ||
| 6-month return | 61.0% | ||
| 12-month return, skipping the last month | 116.6% | ||
| Stability (higher is calmer) | 51 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 40.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.0% | ||
| Liquidity | 82 · Strong | Trades actively. | |
| Average daily value traded | 2.34M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 91 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 7.1% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +5.3% |
|---|---|
| 1 month | +1.8% |
| 3 months | +24.8% |
| 6 months | +61.0% |
| 1 year | +120.6% |
| 3 years | +53.4% |
| 5 years | +226.9% |
Signals
| 50-day / 200-day average | 16.16 / 12.62 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.64 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Oct 2026 | USD 0.5693 |
| 2 Jun 2026 | USD 0.5693 |
| 14 Apr 2026 | USD 0.1423 |
| 6 Jan 2026 | USD 0.0445 |
| 1 Oct 2025 | USD 0.0445 |
| 9 Jul 2024 | USD 1.0229 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Brussels; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.